{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:11:25Z","timestamp":1779912685442,"version":"3.53.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.bbrc.2014.10.039","type":"journal-article","created":{"date-parts":[[2014,10,17]],"date-time":"2014-10-17T01:34:47Z","timestamp":1413509687000},"page":"89-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Novel frame-shift mutation in Slc5a2 encoding SGLT2 in a strain of senescence-accelerated mouse SAMP10"],"prefix":"10.1016","volume":"454","author":[{"given":"Keiko","family":"Unno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masateru","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyo","family":"Takabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Hasegawa-Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuyoshi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0113-8402","authenticated-orcid":false,"given":"Masayuki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.10.039_b0005","series-title":"The Senescence-Accelerated Mouse (SAM): Achievement and Future Directions","first-page":"3","article-title":"Senescence-accelerated mouse (SAM)","author":"Takeda","year":"2013"},{"key":"10.1016\/j.bbrc.2014.10.039_b0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0047-6374(81)90084-1","article-title":"A new murine model of accelerated senescence","volume":"17","author":"Takeda","year":"1981","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbrc.2014.10.039_b0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/ilar.38.3.109","article-title":"Senescence-accelerated mouse (SAM): with special reference to development and pathological phenotypes","volume":"38","author":"Takeda","year":"1997","journal-title":"ILAR J."},{"key":"10.1016\/j.bbrc.2014.10.039_b0020","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0047-6374(02)00091-X","article-title":"A higher oxidative status accelerates senescence and aggravates age-dependent disorders in SAMP strains of mice","volume":"123","author":"Hosokawa","year":"2002","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbrc.2014.10.039_b0025","first-page":"270","article-title":"A novel amyloid fibril protein isolated from senescence-accelerated mice","volume":"47","author":"Matsumura","year":"1982","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2014.10.039_b0030","first-page":"419","article-title":"Immune responses in newly developed short-lived SAM mice. I. Age-associated early decline in immune activities of cultured spleen cells","volume":"62","author":"Hosokawa","year":"1987","journal-title":"Immunology"},{"key":"10.1016\/j.bbrc.2014.10.039_b0035","first-page":"276","article-title":"Age-related changes in bone mass in the senescence-accelerated mouse (SAM). SAM-R\/3 and SAM-P\/6 as new murine models for senile osteoporosis","volume":"125","author":"Matsushita","year":"1986","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2014.10.039_b0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0031-9384(86)90112-5","article-title":"Age-related changes in learning and memory in the senescence-accelerated mouse (SAM)","volume":"38","author":"Miyamoto","year":"1986","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbrc.2014.10.039_b0045","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00005072-199207000-00006","article-title":"Inbred SAM-P\/10 as a mouse model of spontaneous, inherited brain atrophy","volume":"51","author":"Shimada","year":"1992","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbrc.2014.10.039_b0050","series-title":"The Senescence-Accelerated Mouse (SAM): Achievement and Future Directions","first-page":"15","article-title":"Characteristics of a SAM breeding colony at Japan SLC, Inc.","author":"Takagi","year":"2013"},{"key":"10.1016\/j.bbrc.2014.10.039_b0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11064-009-9922-y","article-title":"Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice","volume":"34","author":"Takeda","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbrc.2014.10.039_b0060","doi-asserted-by":"crossref","first-page":"B415","DOI":"10.1093\/gerona\/57.12.B415","article-title":"Age-related progressive neuronal DNA damage associated with cerebral degeneration in a mouse model of accelerated senescence","volume":"57","author":"Shimada","year":"2002","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bbrc.2014.10.039_b0065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/syn.10209","article-title":"Age-related loss of synapses in the frontal cortex of SAMP10 mouse: a model of cerebral degeneration","volume":"48","author":"Shimada","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.bbrc.2014.10.039_b0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2990.2007.00878.x","article-title":"Limbic structures are prone to age-related impairments in proteasome activity and neuronal ubiquitinated inclusions in SAMP10 mouse: a model of cerebral degeneration","volume":"34","author":"Shimada","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbrc.2014.10.039_b0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1440-1789.2010.01126.x","article-title":"Morphological impairments in microglia precede age-related neuronal degeneration in senescence-accelerated mice","volume":"31","author":"Hasegawa-Ishii","year":"2011","journal-title":"Neuropathology"},{"key":"10.1016\/j.bbrc.2014.10.039_b0080","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1474-9726.2008.00394.x","article-title":"Age-related increase of superoxide generation in the brains of mammals and birds","volume":"7","author":"Sasaki","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbrc.2014.10.039_b0085","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.exger.2004.03.033","article-title":"Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10)","volume":"39","author":"Unno","year":"2004","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bbrc.2014.10.039_b0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10522-007-9085-7","article-title":"Decline in glutathione peroxidase activity is a reason for brain senescence: consumption of green tea catechin prevents the decline in its activity and protein oxidative damage in ageing mouse brain","volume":"8","author":"Kishido","year":"2007","journal-title":"Biogerontology"},{"key":"10.1016\/j.bbrc.2014.10.039_b0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10522-006-9036-8","article-title":"Daily consumption of green tea catechin delays memory regression in aged mice","volume":"8","author":"Unno","year":"2007","journal-title":"Biogerontology"},{"key":"10.1016\/j.bbrc.2014.10.039_b0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/biof.5520340402","article-title":"Daily ingestion of green tea catechins from adulthood suppressed brain dysfunction in aged mice","volume":"34","author":"Unno","year":"2008","journal-title":"BioFactors"},{"key":"10.1016\/j.bbrc.2014.10.039_b0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1248\/bpb.34.311","article-title":"Beta-cryptoxanthin, plentiful in Japanese mandarin orange, prevents age-related cognitive dysfunction and oxidative damage in senescence-accelerated mouse brain","volume":"34","author":"Unno","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrc.2014.10.039_b0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/taap.2001.9321","article-title":"Differential regulation of mouse kidney sodium-dependent transporters mRNA by cadmium","volume":"177","author":"Tabatabai","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbrc.2014.10.039_b0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2215\/CJN.04010609","article-title":"Familial renal glucosuria and SGLT2: from a Mendelian trait to a therapeutic target","volume":"5","author":"Santer","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2014.10.039_b0120","doi-asserted-by":"crossref","first-page":"C14","DOI":"10.1152\/ajpcell.00388.2010","article-title":"Glucose transport by human renal Na+\/d-glucose cotransporters SGLT1 and SGLT2","volume":"300","author":"Hummel","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrc.2014.10.039_b0125","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/physrev.00055.2009","article-title":"Biology of human sodium glucose transporters","volume":"91","author":"Wright","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bbrc.2014.10.039_b0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1681\/ASN.2010030246","article-title":"SGLT2 mediates glucose reabsorption in the early proximal tubule","volume":"22","author":"Vallon","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2014.10.039_b0135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1248\/bpb.29.114","article-title":"Reduction of renal transport maximum for glucose by inhibition of Na+-glucose cotransporter suppresses blood glucose elevation in dogs","volume":"29","author":"Ueta","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrc.2014.10.039_b0140","doi-asserted-by":"crossref","first-page":"F188","DOI":"10.1152\/ajprenal.00518.2013","article-title":"Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia","volume":"306","author":"Rieg","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bbrc.2014.10.039_b0145","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00467-012-2109-9","article-title":"Familial renal glucosuria: a clinicogenetic study of 23 additional cases","volume":"27","author":"Lee","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbrc.2014.10.039_b0150","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00439-010-0927-z","article-title":"Abnormal expression and dysfunction of novel SGLT2 mutations identified in familial renal glucosuria patients","volume":"129","author":"Yu","year":"2011","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbrc.2014.10.039_b0155","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.metabol.2014.06.018","article-title":"The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors","volume":"63","author":"Wilding","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.bbrc.2014.10.039_b0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1758-5996-6-73","article-title":"A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy","volume":"6","author":"Orme","year":"2014","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.bbrc.2014.10.039_b0165","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/jcpt.12077","article-title":"The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors","volume":"38","author":"Cangoz","year":"2013","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.bbrc.2014.10.039_b0170","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/dom.12064","article-title":"Inhibition of the sodium glucose co-transporter-2: its beneficial action and potential combination therapy for type 2 diabetes mellitus","volume":"15","author":"Chen","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbrc.2014.10.039_b0175","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.brainresrev.2007.09.001","article-title":"Common pathological processes in Alzheimer disease and type 2 diabetes: a review","volume":"56","author":"Li","year":"2007","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbrc.2014.10.039_b0180","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in Alzheimer disease","volume":"53","author":"Janson","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2014.10.039_b0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/rej.2011.1289","article-title":"Can Alzheimer disease be a form of type 3 diabetes?","volume":"15","author":"Accardi","year":"2012","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.bbrc.2014.10.039_b0190","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.diabres.2012.05.013","article-title":"Type 2 diabetes and\/or its treatment leads to less cognitive impairment in Alzheimer\u2019s disease patients","volume":"98","author":"Dom\u00ednguez","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbrc.2014.10.039_b0195","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/aje\/kws387","article-title":"Earlier age of dementia onset and shorter survival times in dementia patients with diabetes","volume":"177","author":"Zilkens","year":"2013","journal-title":"Am. J. Epidemiol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14018373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14018373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:52:47Z","timestamp":1717462367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14018373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0006291X14018373"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.039","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel frame-shift mutation in Slc5a2 encoding SGLT2 in a strain of senescence-accelerated mouse SAMP10","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}